newsfilter
← Latest News
PR Newswire·

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine

LogicBio acquisition to build on current collaborations and advancements in genomic medicine LEXINGTON, Mass., Oct. 3, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a pioneering clinical-stage genomic medicine company, today